iMedrix provides diagnostic solutions producing clinical grade ECG traces with device accuracy proved in more than 450,000 ECGs across 15 countries. iMedrix is committed to revolutionising cardiac health care with its Artificial intelligence (AI), Cloud Technology, and Machine learning (ML) for quick diagnosis and accurate clinical decisions. iMedrix provides cutting-edge medical technology through KardioScreen, a totally mobile, connected 12 & 6 lead, US FDA-cleared electrocardiogram (ECG or EKG). KardioScreen from iMedrix is an innovative, US FDA cleared, mobile-connected ECG/EKG device that simplifies the process of heart monitoring and risk assessment in a wide variety of in-hospital, emergency response, home care, primary care and outreach settings.